22nd Century Group is well aware that its short- and long-term futures are dependent a potential lifeline from the Biden administration for its cigarettes that contain 95% less nicotine than ...

22nd Century’s cash requirements are anticipated to decrease, reflecting higher sales volume of higher margin contract manufacturing operations cigarettes and VLN products through fiscal 2023 ...

The short- and long-term mission — and fate — of 22nd Century Group Inc. has arrived at a crossroads of contradictions. The Mocksville tobacco manufacturer’s existence is based on becoming a ...

Adjusted EBITDA was a loss of $14.7 million, compared to prior year loss of $6.6 million. “22nd Century is executing an aggressive commercial rollout of our FDA authorized VLN reduced nicotine ...

22nd Century Group is a mispriced agricultural biotechnology company that is poised to transform the global tobacco and hemp/cannabis markets. Shares are down 60% during the past month ...

22nd Century Group already makes FDA-authorized reduced-nicotine-content cigarettes that would still be sellable if the new standards are ultimately adopted, so it could expect higher revenue ...